IFP Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
3934
2024
Q4
Hold
0
3851
2022
Q4
Sell
-7
Closed -$3K 4632
2022
Q3
$3K Hold
7
﹤0.01% 4198
2022
Q2
$3K Hold
7
﹤0.01% 3960
2022
Q1
$3K Buy
+7
New +$4.23K ﹤0.01% 3960

Other funds holding CDLX

IFP Advisors's CDLX Position: Q1 2025 in Review

IFP Advisors held its Cardlytics (CDLX) position steady in Q1 2025 at 0 shares worth $76. The position accounts for ﹤0.01% of the portfolio, ranked #3934.

IFP Advisors first reported a position in CDLX in Q1 2022 and has held it in 3 quarters since. The position peaked at $3K in Q3 2022. 108 funds tracked by Wall St. Rank hold CDLX as of Q1 2025.

  • IFP Advisors held 0 shares of Cardlytics worth $76 as of Q1 2025.
  • IFP Advisors left its Cardlytics share count unchanged in Q1 2025.
  • Cardlytics made up ﹤0.01% of IFP Advisors's portfolio in Q1 2025, its #3934 holding.
  • IFP Advisors first reported a position in Cardlytics in Q1 2022 and has held it in 3 quarters since.
  • IFP Advisors's Cardlytics position peaked at $3K in Q3 2022.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.